These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21778619)

  • 1. [Glucose intolerance and dementia].
    Sakurai T
    Nihon Ronen Igakkai Zasshi; 2011; 48(2):107-10. PubMed ID: 21778619
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with diabetes and impaired glucose tolerance--is it feasible to screen for depression?
    Wright MJ; White A; Glover M; Lewin TJ; Harmon KD
    Aust Fam Physician; 2005 Jul; 34(7):607-8. PubMed ID: 15999176
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive glucose control and cardiovascular outcomes in diabetes and impaired glucose tolerance].
    Waki K; Kadowaki T
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():573-8. PubMed ID: 22519054
    [No Abstract]   [Full Text] [Related]  

  • 4. A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment.
    Podell BK; Ackart DF; Richardson MA; DiLisio JE; Pulford B; Basaraba RJ
    Dis Model Mech; 2017 Feb; 10(2):151-162. PubMed ID: 28093504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal glycemic metabolism in essential hypertension. Role of the oral glucose tolerance test].
    García-Puig J; Luque-Otero M; Ruilope-Urioste LM
    Med Clin (Barc); 2006 Jan; 126(3):116-7; author reply 117. PubMed ID: 16472488
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormal glycemic metabolism in essential hypertension. Role of the oral glucose tolerance test].
    Bernardino JI; Martínez MA; García-Puig J;
    Med Clin (Barc); 2006 Jan; 126(3):116; author reply 117. PubMed ID: 16472489
    [No Abstract]   [Full Text] [Related]  

  • 7. Pioglitazone in nonalcoholic steatohepatitis.
    Targher G
    N Engl J Med; 2007 Mar; 356(10):1067; author reply 1068-9. PubMed ID: 17347462
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysglycaemia and risk of cardiovascular disease.
    Yudkin JS; Coppack S
    Lancet; 1996 Jun; 347(9018):1834. PubMed ID: 8667945
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysglycaemia and risk of cardiovascular disease.
    Jarrett RJ
    Lancet; 1996 Jun; 347(9018):1833-4. PubMed ID: 8667944
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine.
    Dominiczak MH
    Clin Chem Lab Med; 2003 Sep; 41(9):1266-78. PubMed ID: 14598880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucose intolerance in obese children and adolescents].
    Yeste D; Betancourth S; Gussinyé M; Potau N; Carrascosa A
    Med Clin (Barc); 2005 Oct; 125(11):405-8. PubMed ID: 16216184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysglycaemia and risk of cardiovascular disease.
    Gerstein HC; Yusuf S
    Lancet; 1996 Apr; 347(9006):949-50. PubMed ID: 8598762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence and prognostic significance of pathological glucose metabolism in acute myocardial infarction].
    Egstrup M; Henriksen FL; Høfsten DE; Hangaard J; Egstrup K
    Ugeskr Laeger; 2008 Mar; 170(11):940-2. PubMed ID: 18397621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-prandial hyperglycemia and microvascular complications.
    Dhanwal D; Tandon N
    J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].
    Tanaka Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():361-5. PubMed ID: 15779404
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
    Ann Intern Med; 2005 Mar; 142(5):I28. PubMed ID: 15738446
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes mellitus and epidemiology: apropos of the meeting on the epidemiology of diabetes mellitus].
    Simon D
    Pathol Biol (Paris); 1994 Feb; 42(2):129-32. PubMed ID: 8090556
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathophysiology of type 2 diabetes mellitus].
    Kaneto H
    Nihon Rinsho; 2015 Dec; 73(12):2003-7. PubMed ID: 26666144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.